In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors

European Journal of Pharmaceutical Sciences

Volumn 35, Issue 5, 2008, Pages 404-416

  Jain, Anekant ^a   Jain, Sanjay K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

5FU; Cell cytotoxicity studies; Chitosan nanoparticles; Colon targeted drug delivery; Colon tumors; Colorectal cancer; HT 29 cancer cell lines

Indexed keywords

CHITOSAN; FLUOROURACIL; HYALURONIC ACID; HYALURONIC ACID COUPLED CHITOSAN NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CELL STRAIN HT29; COLON TUMOR; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG UPTAKE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; NANOENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; STOMACH PH; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; CHITOSAN; COLON; COLONIC NEOPLASMS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; ELECTROCHEMISTRY; EXCIPIENTS; FLUOROURACIL; HT29 CELLS; HUMANS; HYALURONIC ACID; LIGANDS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; PHOTOMETRY; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 55949096698     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2008.08.008     Document Type: Article

References (47)

1. Akima K., Ito H., Iwata Y., Matsuo K., Watari N., Yanagi M., Hagi H., Oshima K., Yagita A., Atomi Y., and Tatekawa I. Evaluation of antitumor activities of hyaluronate binding antitumor drugs: synthesis, characterization and antitumor activity. J. Drug Target. 4 (1996) 1-8
2. Babu V.R., Sairam M., Hosamani K.M., and Aminabhavi T.M. Development of 5-fluorouracil loaded poly(acrylamide-co-methylmethacrylate) novel core-shell microspheres: in vitro release studies. Int. J. Pharm. 325 (2006) 55-62
3. Bel M.K., Weichert W., Well K.C., Schmitt W.D., Lautenschlager C., and Hauptmann S. Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis. Virchows Arch. 445 (2004) 456-464
4. Bitter T., and Muir H.M. A modified uronic acid carbozole reaction. Anal. Biochem. 4 (1962) 330-334
5. Bourguignon L.Y.W., Zhu H.B., Shao L.J., and Chen Y.W. CD44 interaction with Tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. J. Biol. Chem. 275 (2000) 1829-1838
6. Calabresi P., and Chabner B.A. Chemotherapy of neoplastic diseases. In: Hardman J.G., Limbird L.E., Perry B.M., and Raymond W.R. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics (1996), McGraw-Hill, New Delhi, India 1381-1388
7. Calvo P., Lopez C.R., Jato J., and Alonso M.J. Hydrophilic chitosan polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 63 (1997) 125-132
8. Couvreur P., and Vauthier C. Polyalkylcyanoacrylate nanoparticles as drug carrier, present state and perspectives. J. Controlled Release 17 (1991) 187-198
9. Culty M., Shizari M., Thompson E.W., and Underhill C.B. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. J. Cell. Physiol. 160 (1994) 275-286
10. Day A.J., and Prestwich G.D. Hyaluronan-binding proteins: tying up the giant. J. Biol. Chem. 277 (2002) 4585-4588
11. Dische Z.J. Specific color reaction of hexuronic acids. Biol. Chem. 167 (1947) 189-198
12. Dubernet C. Thermo analysis of microspheres. Thermochim. Acta 248 (1995) 259-269
13. Fry D.W., White J.C., and Goldman I.D. Rapid separation of low molecular weight solutes from liposomes without dilution. J. Anal. Biochem. 90 (1978) 803-807
14. Gokhale P.C., Radhakrishnan B., Husain S.R., Abernethy D.R., Sacher R., Dritschilo A., and Rahman A. An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation. Br. J. Cancer 34 (1996) 45-48
15. Gupta Y., Jain A., Jain P., and Jain S.K. Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumor cells. J. Drug Target. 15 3 (2007) 231-240
16. Hahn R.G., Moertel C.G., Schutt A.J., and Bruckner H.W. A double-blind comparison of intensive course 5-fluorouracil by oral vs. intravenous route in the treatment of colorectal carcinoma. Cancer 35 (1975) 1031-1035
17. Hirano S., Seino H., Akiyama I., and Nonaka I. Chitosan: a biocompatible material for oral and intravenous administration. In: Geblein C.G., and Dunn R.L. (Eds). Progress in Biomedical Polymers (1990), Plenum, New York 283-289
18. Hua Q., Knudson C.B., and Knudson W. Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J. Cell Sci. 106 (1993) 365-375
19. Jain A., Gupta Y., and Jain S.K. Azo-chemistry and its potential for colonic delivery. Crit. Rev. Ther. Drug Carrier Syst. 23 5 (2006) 349-400
20. Jain A., Gupta Y., and Jain S.K. Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon. J. Pharm. Pharmaceut. Sci. 10 1 (2007) 86-128
21. Jain A., Gupta Y., and Jain S.K. Potential of calcium pectinate beads for target specific drug release to colon. J. Drug Target. 15 4 (2007) 285-294
22. Jain S.K., Chaurasiya A., Gupta Y., Jain A., Dagur P., Joshi B., and Katoch V.M. Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumor targeting. J. Microencap. 25 5 (2008) 289-297
23. Knaul J.Z., Hudson S.M., and Creber K.A.M. Improved mechanical properties of chitosan fibers. J. Appl. Polym. Sci. 72 (1999) 1721-1731
24. Knapczyk J., Krowczynski L., Krzek J., Brzeski M., Nurnberg E., Schnek O., and Struszcyk H. Requirements of chitosan for pharmaceutical and biomedical applications. In: Skak-Braek G., Anthonsen T., and Sandford P. (Eds). Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications (1989), Elsevier, London 657-663
25. Knudson W. Tumor-associated hyaluronan: providing an extracellular matrix that facilitates invasion. Am. J. Pathol. 148 (1996) 1721-1726
26. Krishnaiah Y.S.R., and Satyanarayan S. Colon-specific drug delivery systems. In: Jain N.K. (Ed). Advances in Controlled and Novel Drug Delivery (2001), CBS Publishers and Distributors, New Delhi, India 89-119
27. Lee R.J., and Low P.S. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269 (1994) 3198-3204
28. Lokeshwar V.B., Obek C., Pham H.T., Wei D., Young M.J., Duncan R.C., Soloway M.S., and Block N.L. Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade. J. Urol. 163 (2000) 348-356
29. Luo Yi., Bernshaw N.J., Lu Z.R., Kopecek J., Prestwich, and Glenn D. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates. Pharmaceut. Res. 19 4 (2002) 15-21
30. Luo Y., and Prestwich G.D. Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjug. Chem. 10 (1999) 755-763
31. Michor F., Iwasa Y., Lengauer C., and Nowak N.A. Dynamics of colorectal cancer. Semin. Cancer Biol. 15 (2005) 484-493
32. Mossmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
33. Mu L., and Feng S.S. Fabrication characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. J Controlled Release 76 (2001) 239-254
34. Panyam J., Dali M.M., Sahoo S.K., Ma W., Chakravarthi S.S., Amidon G.L., and Levy R.J. Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticles. J. Controlled Release 92 1-2 (2003) 173-187
35. Peterson R.M., Yu Q., Stamenkovic I., and Toole B.P. Pertur-bation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites. Am. J. Pathol. 156 (2000) 2159-2167
36. Prestwich, G.D., 2001. Biomaterials from chemically modified hyaluronan. Glycoforum .
37. Samuelsson C., and Gustafson S. Studies on the interaction between hyaluronan and a rat colon cancer cell line. Glycoconjugate J. 15 (1998) 169-175
38. Souder J.C., and Ellenbogen W.C. Control of d-amphetamine sulphate sustained release capsule. Drug Standards 26 (1985) 77-79
39. Steuer H., Jaworski A., Stoll D., and Schlosshauer B. In vitro model of the outer blood-retina barrier. Brain Res. Protocols 13 1 (2004) 26-36
40. Stevens P., and Lee R.J. Development of a folic acid receptor-targeted emulsion of paclitaxel. Anticancer Res. 23 4 (2003) 4927-4932
41. Turley E.A., Belch A.J., Poppema S., and Pilarski L.M. Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes. Blood 81 3 (1993) 446-453
42. Wang C., Tammi M., Guo H., and Tammi R. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am. J. Pathol. 148 6 (1996) 12-18
43. Yamada Y., Itano N., Narimatsu H., Kudo T., Hirohashi S., Ochiai A., Nimi A., Ueda M., and Kimata K. Receptor for hyaluronan-mediated motility and CD44 expressions in colon cancer assessed by quantitative analysis using real-time reverse transcriptase-polymerase chain reaction. Jpn. J. Cancer Res. 90 (1999) 987-992
44. Yoo H.S., and Park T.G. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J. Controlled Release 70 (2001) 63-70
45. Yu J.H., Du Y.M., and Zheng H. Blend films of chitosan gelation. J. Wuhan Univ. (Nal. Sci. Ed.) 45 (1999) 440-444
46. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D.A., Torchilin V.P., and Jain R.K. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 55 (1995) 3752-3756
47. Zeng C.X., Toole B.P., Kinney S.D., Kuo J.W., and Stamenkovic I. Inhibition of tumor growth in vivo by hyaluronan oligomers. Int. J. Cancer 77 (1998) 396-401